Enrique Sta Ana, MD
Surgery · Houston, TXNPI 1669499612
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Intuitive Surgical at 56.1% of the total. Reporting peaked in 2019 at $12,257 and has fallen 82.1% since, to $2,196 in 2024.
Across 81 payments — averaging $222.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- AbbVie$4K
- TELA Bio, Inc.$2K
- Davol Inc.$901
- Stryker$446
- Baxter Healthcare$272
- plus $634 from 10 others
What the payments were for
- Travel & lodging$4,77126%
- Food & beverage$5,23929%
- Education$8,00044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $10,106 |
| AbbVie(2 entities) | 23 | $3,605 |
| TELA Bio, Inc. | 9 | $2,045 |
| Davol Inc. | 12 | $901 |
| Stryker | 3 | $446 |
| Baxter Healthcare | 2 | $272 |
| Innocoll Pharmaceuticals Limited | 2 | $161 |
| Medtronic | 1 | $117 |
| Johnson & Johnson | 2 | $95 |
| Cumberland Pharmaceuticals, Inc. | 2 | $84 |
| Pacira Pharmaceuticals Incorporated | 2 | $43 |
| Merck | 2 | $35 |
| Shire North American Group Inc | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$9,639
- OviTex 2S$1,724
- ALLODERM$1,356
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,198
- NATRELLE SALINE-FILLED BREAST IMPLANTS$823
- PHASIX$523
- STRATTICE$410
- PerClot$272
- Phasix Mesh$189
- 1788$154
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$151
- SPY-PHI SYSTEM$148
- XARACOLL$147
- 1688$144
- Situate$117
How this compares
$18,009 in reported general payments places this provider in the 85th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 62 | $238 |
Paid to pharmacies, not to this prescriber.
Other surgery in Houston
- James SuliburkHouston$161K
- Funda MericHouston$141K
- Jonathan StahlHouston$105K
- Richard KnightHouston$103K
- Tanyaradzwa KajeseHouston$92K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.